Development of Novel Zn²⁺ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences

• Andreas M. Grabrucker ,

  * E-mail: andreas.grabrucker@stanford.edu (AMG); giovanni.tosi@unimore.it (GT)

  Affiliations Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford University, Stanford, California, United States of America, Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany

  ⨯
• Craig C. Garner,

  Affiliation Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford University, Stanford, California, United States of America

  ⨯
• Tobias M. Boeckers,

  Affiliation Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany

  ⨯
• Lucia Bondioli,

  Affiliation Te.Far.T.I. Group, Pharmaceutical Technology, Department of Pharmaceutical Science, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

  ⨯
• Barbara Ruozi,

  Affiliation Te.Far.T.I. Group, Pharmaceutical Technology, Department of Pharmaceutical Science, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

  ⨯
• Flavio Forni,

  Affiliation Te.Far.T.I. Group, Pharmaceutical Technology, Department of Pharmaceutical Science, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

  ⨯
• Maria Angela Vandelli,

  Affiliation Te.Far.T.I. Group, Pharmaceutical Technology, Department of Pharmaceutical Science, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

  ⨯
• Giovanni Tosi

  * E-mail: andreas.grabrucker@stanford.edu (AMG); giovanni.tosi@unimore.it (GT)

  Affiliation Te.Far.T.I. Group, Pharmaceutical Technology, Department of Pharmaceutical Science, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

  ⨯